Paasa Logo
Processa Pharmaceuticals, Inc. logo
PCSANASDAQMarket closedOpens 9:30am ET

Processa Pharmaceuticals, Inc.

$1.76Last updated
-$0.08 (4.35%)Past day
Timezone

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) is trading at $1.76, about ₹169 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 4.35% today. Indian residents can buy Processa Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.82
Previous close:$1.84
Volume:9.21K

Today's low

$1.75

Today's high

$1.83

52 week low

$1.67

52 week high

$14.25

PCSA opened at $1.82, closed previously at $1.84, and has traded between $1.67 and $14.25 over the past 52 weeks.

About

Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative and non-ulcerative manifestations of necrobiosis lipoidica, a chronic and disfiguring dermatological condition. Processa's portfolio also features PCS12852, a unique selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist. This compound is currently in Phase 2A clinical trials for its potential application in managing gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia. Furthermore, the firm is advancing PCS3117, a cytosine analog, which has reached Phase 2B clinical trials for its use in pancreatic cancer and non-small cell lung cancer. Another candidate, PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase, is progressing through Phase 1B clinical trials for metastatic colorectal and breast cancers. In addition, Processa is developing PCS11T, an analog derived from the drugs SN38 and irinotecan, intended for the treatment of diverse cancer types. The company was founded in 2011 and maintains its corporate headquarters in Hanover, Maryland.

Country
US
CEO
George K. Ng
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
12
Sector
Healthcare
IPO date
07/03/2014

Key statistics

Avg. volume

182.38K

Market cap

$4.87M

P/E Ratio

-0.31

Price-to-sales ratio

0.00

Enterprise value

-$1.77M

Free cash flow yield

-301.94%

Debt-to-equity ratio

0.00

Return on equity

-243.20%

ROIC

-250.81%

Beta

0.97

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$10.36

Free cash flow

-$11.39M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$13.56M

Revenue growth

0.00%

Similar securities

This is not an investment recommendation

How to buy Processa Pharmaceuticals from India

Indian residents can buy Processa Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Processa Pharmaceuticals and place an order

    Find Processa Pharmaceuticals by name or by its ticker, PCSA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Processa Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Processa Pharmaceuticals position in USD and INR. Processa Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Processa Pharmaceuticals from India

Trading and taxes when buying Processa Pharmaceuticals from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneProcessa Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Processa Pharmaceuticals stock?

Yes. Processa Pharmaceuticals (PCSA) has been listed on NASDAQ since 2014, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Processa Pharmaceuticals share cost in rupees?

One Processa Pharmaceuticals share is $1.76 — about ₹169 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Processa Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Processa Pharmaceuticals from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Processa Pharmaceuticals?

Yes. One Processa Pharmaceuticals share is $1.76, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Processa Pharmaceuticals.

How are gains on Processa Pharmaceuticals shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Processa Pharmaceuticals price. Paasa issues a capital-gains statement for your return.

Does Processa Pharmaceuticals pay a dividend?

No. Processa Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Processa Pharmaceuticals from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Processa Pharmaceuticals shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Processa Pharmaceuticals shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Processa Pharmaceuticals holding, its cost and its closing value.

How do I sell Processa Pharmaceuticals and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.